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MORNING-AFTER PILL FOR SUNTAN
Early treatment of sunburn with cyclo-oxygenase inhibitors may reduce skin cancers, as suggested by the study from St. Louis and Rochester.
Prostaglandin (PG) synthesis increases as part of a repair response to UV light; however, this may be associated with the persistence of cells
with mutated DNA sequences, which could evolve into cancers. Inhibition of keratinocyte PG synthesis with potent PG inhibitors increased
apoptosis and may eliminate those mutated cells. The morning-after pill for suntan would be an important addition to the beach bag. ( J Invest
Dermatol 121:853^861, 2003)
COX-2 AND PRECOCIOUS CATAGEN
Topical prostaglandin for glaucoma increases eyelash growth; some
patients treated with cyclo-oxygenase inhibitors develop alopecia.
Muº ller-Decker and coworkers report that COX-2 expression in the
basal layer of the hair follicle and the epidermis leads to premature
catagen and alopecia in mouse skin. In these transgenic animals the
alopecia was prevented with a COX-2 inhibitor. Considering the
common use of COX-2 inhibitors, hair-related e¡ects in patients
should be closely investigated. ( J Invest Dermatol 121:661^668, 2003)
ENERGY SHORTAGE IN HAILEY-HAILEY
KERATINOCYTES
Actin, a ubiquitous component of the cytoskeleton, cannot be properly
reorganized in Hailey-Hailey (HH) keratinocytes and is associated with
low ATP levels in HH cells. Actin polymerization and ¢lopodia are
among the ¢rst responses to increased calcium.When actinomycin was
used in normal keratinocytes to inhibit oxidative phosphorylation, the
HH phenotype was reproduced. Aronchick and coworkers found the
cytoskeleton of HH keratinocytes did not organize after stimulation by
increased calcium and the normal extension of the cytoskeleton to the
plasma membrane did not occur. ( J Invest Dermatol 121:681^687, 2003)
HOUSEKEEPING GENES DO
GOODWORK
Housekeeping genes are usually thought to be the
‘‘grunts’’of the cellquietly doing important but essen-
tially dull jobs such as making ATP and keeping meta-
bolic pathways neat and clean. It is remarkable that a
de¢ciency of one enzyme, the gene for fumarate hydra-
tase, an enzyme of the Krebs cycle, is associated with
cutaneous and uterine leimyomas in families around
the world, as reported by Martinez-Mir and colleagues.
This disorder raises fundamental questions about the
relations among energy metabolism, proliferation and
malignancy that may be addressed by studying the cells
from these patients and their homologous mouse mod-
els. ( J Invest Dermatol 121:741^744, 2003)
AS2O3 FORCTCL
When Sezary was describing his ‘‘monster’’ cells, or-
ganic arsenicals were part of the therapy for syphilis.
Inorganic arsenic is a known carcinogen and it is in-
triguing that in the era of new recombinant biologi-
cal response molecules arsenic is still of interest. In the
study reported by Michel and coworkers, AS2O3
induced apoptosis, which can be potentiated by ascor-
bic acid and occurs in normal T cells and in the ab-
normal T cells of those with Sezary’s syndrome.
AS2O3 has been used in the treatment of promyelocy-
tic leukemias and may have a potential role in CTCL/
Sezary’s syndrome. ( J Invest Dermatol 121:881^893,
2003)
NEUROPATHY, ULCERS AND GROWTH FACTORS
Diabetes, leprosy, and genetic disorders of growth factors can produce associated skin ulcers and de-
creased Nerve Growth Factor (NGF) levels in the skin. In this article by Kanda andWatanabe, 17-beta-
estradiol (E2) stimulated NGF secretion several-fold in mononuclear cells, although testosterone and
progesterone did not. Tamoxifen, an estrogen antagonist, did not alter NGF. Detailed molecular studies
demonstrated that membrane-associated E2 and not the nuclear steroid receptor for E2 was the important
component of mediating this response. Cyclic AMP was the mediator of the estrogen response membrane-
related response. These ¢ndings may lead to hormonal and growth factor treatment of skin ulcers.
( J Invest Dermatol 121:771^780, 2003)
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